Benzenesulfonamide,N-[[[(1S,2S,3R,4R)-3-hydroxy-4,7,7-trimethylbicyclo[2.2.1]hept-2-yl]amino]carbonyl]-4-methyl- cas no:26944-48-9

NameBenzenesulfonamide,N-[[[(1S,2S,3R,4R)-3-hydroxy-4,7,7-trimethylbicyclo[2.2.1]hept-2-yl]amino]carbonyl]-4-methyl-
CAS26944-48-9
SynonymsBenzenesulfonamide,N-[[(3-hydroxy-4,7,7-trimethylbicyclo[2.2.1]hept-2-yl)amino]carbonyl]-4-methyl-,[1S-(endo,endo)]-; Urea, 1-(2-hydroxy-3-bornyl)-3-(p-tolylsulfonyl)-,(1R,2R,3S,4S)- (8CI); Glibornuride; Gluboride; Glutril; Ro 6-4563; Ro 6-4563/8;endo, endo-1-[(1R)-(2-Hydroxy-3-bornyl)]-3-(p-tolylsulfonyl)urea;endo,endo-1-(2-Hydroxy-3-bornyl)-3-(p-tolylsulfonyl)urea
EINECS(EC#)248-124-6
Molecular FormulaC18H26 N2 O4 S
Molecular Weight366.52

refractive index1.6

Safety

Moderately toxic by intraperitoneal route. Mildly toxic by ingestion. Experimental teratogenic and reproductive effects. When heated to decomposition it emits toxic fumes of SO_x and NO_x.

1.		orl-rat LD50:18 g/kg		KSRNAM    Kiso to Rinsho. Clinical Report. 6 (1972),1925.
2.		ipr-rat LD50:1360 mg/kg		KSRNAM    Kiso to Rinsho. Clinical Report. 6 (1972),1925.
3.		scu-rat LD50:10,800 mg/kg		KSRNAM    Kiso to Rinsho. Clinical Report. 6 (1972),1925.
4.		ipr-mus LD50:1530 mg/kg		KSRNAM    Kiso to Rinsho. Clinical Report. 6 (1972),1925.
5.		scu-mus LD50:20 g/kg		KSRNAM    Kiso to Rinsho. Clinical Report. 6 (1972),1925.